Meanwhile, Lin et al. [21] suggested that FOXO3 is downregulated in sorafenib-resistant HCC under hypoxia, leading to autophagy activation and sorafenib resistance enhancement. Here, FOXO3 is linked to hepatocellular carcinoma.